Directors of the California stem cell agency today expanded eligibility for the $100 million disease team round to include some earlier recipients in its early translational rounds.
Ellen Feigal, vice president for research and development, said some of those grantees are likely to be ready for more funding as they move closer to clinical trials. She said if they cannot apply in this round, they may have to wait for another year.
Directors agreed that it was important to avoid gaps in funding on successful programs. The RFA could be posted very soon.
No comments:
Post a Comment